Intensity of Symptoms and Perception of Quality of Life on Admission to Palliative Care: Reality of a Portuguese Team.

Florbela Gonçalves, Margarida Gaudêncio, Ivo Cristiano Soares Paiva, Francisca Rego, Rui Nunes
Author Information
  1. Florbela Gonçalves: Portuguese Institute of Oncology Francisco Gentil Coimbra, 3000-075 Coimbra, Portugal. ORCID
  2. Margarida Gaudêncio: Portuguese Institute of Oncology Francisco Gentil Coimbra, 3000-075 Coimbra, Portugal. ORCID
  3. Ivo Cristiano Soares Paiva: Health Sciences Research Unit: Nursing, Nursing School of Coimbra, 3000-232 Coimbra, Portugal. ORCID
  4. Francisca Rego: Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal. ORCID
  5. Rui Nunes: Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal. ORCID

Abstract

BACKGROUND: Palliative care (PC) corresponds to an approach that enhances the quality of life for patients facing life-threatening diseases, such as cancer, as well as for their families. There are various models for providing palliative care. Early referral to PC of patients with advanced cancer has a significant positive impact on their quality of life. However, the criteria for early referral still remain controversial.
OBJECTIVES: To evaluate patients' symptomatic intensity and perception of quality of life on admission to a PC unit and to analyze these two variables according to different models of approach (outpatient and inpatient care).
METHODS: A cross-sectional, descriptive, and correlational study was conducted with a sample of 60 patients sequentially admitted to a PC unit from palliative outpatient consultations or other inpatient services in a tertiary hospital dedicated to oncology care. The evaluation protocol included a sociodemographic and medical questionnaire, the Edmonton Symptom Assessment Scale (ESAS), and the Palliative Care Outcome Scale (POS) completed by patients within the first 24 h after admission.
RESULTS: The participants were mostly male (61.7%), with a median age of 72 years. The majority of patients ( = 32; 53.3%) were undergoing outpatient treatment, while the remaining individuals ( = 28; 46.7%) were transferred from other hospital services (inpatient care). In the outpatient care group, higher scores for fatigue and dyspnea were observed. Conversely, in the inpatient care group, higher scores were observed for pain, depression, and anxiety. There were significant differences between the two groups regarding the POS dimensions of meaning of life, self-feelings, and lost time. In the inpatient group, there was a longer time between diagnosis and referral to PC; however, it was also in the inpatient group that there was less time between PC referral and first PC evaluation, between PC referral and PC unit admission, and between PC referral and death. There were no significant correlations between referral times and ESAS/POS scores in the inpatient and outpatient groups.
CONCLUSIONS: The patients admitted to the Palliative Care Unit presented a high symptom burden and changes in the perception of quality of life. However, there are no statistically significant differences between one model of approach in relation to the other. It was found that poorer symptom control and quality of life were associated with a shorter referral time for PC, because this was only initiated after curative care was suspended, particularly in our institutional context. Early referrals to the PC team are essential not only to relieve symptom-related distress but also to improve treatment outcomes and quality of life for people with cancer.

Keywords

References

  1. Semin Oncol Nurs. 2014 Nov;30(4):227-33 [PMID: 25361874]
  2. Oncologist. 2021 Feb;26(2):165-171 [PMID: 33252169]
  3. J Pain Symptom Manage. 2009 Aug;38(2):191-6 [PMID: 19515529]
  4. J Clin Oncol. 2017 Jan;35(1):96-112 [PMID: 28034065]
  5. J Pain Symptom Manage. 1996 Nov;12(5):273-82 [PMID: 8942122]
  6. J Palliat Care. 1991 Summer;7(2):6-9 [PMID: 1714502]
  7. BMC Palliat Care. 2020 Mar 24;19(1):37 [PMID: 32209075]
  8. Cureus. 2021 May 29;13(5):e15313 [PMID: 34211813]
  9. BMC Palliat Care. 2005 Feb 22;4(1):3 [PMID: 15725350]
  10. BMC Palliat Care. 2022 Nov 28;21(1):209 [PMID: 36443700]
  11. Qual Health Care. 1999 Dec;8(4):219-27 [PMID: 10847883]
  12. J Palliat Med. 2018 Sep;21(9):1322-1328 [PMID: 29630413]
  13. Oncologist. 2016 Jul;21(7):895-901 [PMID: 27185614]
  14. J Clin Oncol. 2020 Mar 20;38(9):905-914 [PMID: 32023162]
  15. J Pain Symptom Manage. 2016 Jun;51(6):1033-1039.e3 [PMID: 27046299]
  16. Rev Lat Am Enfermagem. 2016 Aug 15;24:e2764 [PMID: 27533273]
  17. J Clin Oncol. 2018 Apr 10;36(11):1096-1102 [PMID: 29474102]
  18. J Clin Oncol. 2010 Sep 1;28(25):4013-7 [PMID: 20660825]
  19. J Pain Symptom Manage. 2006 Jan;31(1):58-69 [PMID: 16442483]
  20. Acta Med Port. 2008 Mar-Apr;21(2):111-24 [PMID: 18625090]
  21. J Pain Symptom Manage. 2011 Feb;41(2):456-68 [PMID: 20832987]
  22. Oncologist. 2020 Aug;25(8):722-728 [PMID: 32445194]
  23. JAMA Netw Open. 2021 Jul 1;4(7):e2117295 [PMID: 34269810]
  24. J Clin Oncol. 2015 May 1;33(13):1438-45 [PMID: 25800768]
  25. J Clin Oncol. 2015 May 1;33(13):1446-52 [PMID: 25800762]
  26. J Community Support Oncol. 2014 Apr;12(4):129-36 [PMID: 24971422]
  27. Cancers (Basel). 2022 Feb 18;14(4): [PMID: 35205793]
  28. Cureus. 2023 Apr 21;15(4):e37930 [PMID: 37220447]
  29. Eur J Health Law. 2006 Sep;13(3):293-301 [PMID: 17190358]
  30. Oncologist. 2021 Apr;26(4):332-340 [PMID: 33284483]
  31. Palliat Care. 2017 Feb 20;10:1178224216688887 [PMID: 28469439]
  32. J Pain Symptom Manage. 2015 Dec;50(6):842-53.e19 [PMID: 26335764]
  33. Biomol Ther (Seoul). 2018 Jul 1;26(4):335-342 [PMID: 29949843]
  34. Indian J Palliat Care. 2011 Jan;17(Suppl):S14-6 [PMID: 21811360]
  35. Lancet. 2018 Apr 7;391(10128):1391-1454 [PMID: 29032993]
  36. J Pain Symptom Manage. 2017 Mar;53(3):630-643 [PMID: 28042071]
  37. N Engl J Med. 2010 Aug 19;363(8):733-42 [PMID: 20818875]
  38. Lancet. 2014 May 17;383(9930):1721-30 [PMID: 24559581]
  39. JAMA. 2013 Nov 27;310(20):2191-4 [PMID: 24141714]
  40. Ann Palliat Med. 2015 Jul;4(3):99-121 [PMID: 26231807]
  41. Ann Oncol. 2012 Aug;23(8):2006-2015 [PMID: 22345118]
  42. Support Care Cancer. 2022 Jan;30(1):931-940 [PMID: 34417885]
  43. J Palliat Med. 2012 Dec;15(12):1356-61 [PMID: 23045990]
  44. Clin Nurs Res. 2016 Apr;25(2):174-91 [PMID: 25550305]
  45. Cancers (Basel). 2022 May 20;14(10): [PMID: 35626129]
  46. Palliat Med. 2011 Jun;25(4):304-13 [PMID: 21464119]
  47. JAMA Oncol. 2016 May 01;2(5):591-598 [PMID: 26768772]
  48. Cancer Nurs. 1996 Aug;19(4):298-307 [PMID: 8768688]
  49. Oncologist. 2012;17(12):1574-80 [PMID: 23220843]

Word Cloud

Created with Highcharts 10.0.0PCcarelifereferralqualityinpatientpatientsoutpatientPalliativesignificantgrouptimeapproachcancerpalliativeadmissionunitscoressymptommodelsEarlyHoweverperceptiontwoadmittedserviceshospitaloncologyevaluationmedicalScaleCarePOSfirst7%=treatmenthigherobserveddifferencesgroupsalsoassessmentBACKGROUND:correspondsenhancesfacinglife-threateningdiseaseswellfamiliesvariousprovidingadvancedpositiveimpactcriteriaearlystillremaincontroversialOBJECTIVES:evaluatepatients'symptomaticintensityanalyzevariablesaccordingdifferentMETHODS:cross-sectionaldescriptivecorrelationalstudyconductedsample60sequentiallyconsultationstertiarydedicatedprotocolincludedsociodemographicquestionnaireEdmontonSymptomAssessmentESASOutcomecompletedwithin24hRESULTS:participantsmostlymale61medianage72yearsmajority32533%undergoingremainingindividuals2846transferredfatiguedyspneaConverselypaindepressionanxietyregardingdimensionsmeaningself-feelingslostlongerdiagnosishoweverlessdeathcorrelationstimesESAS/POSCONCLUSIONS:Unitpresentedhighburdenchangesstatisticallyonemodelrelationfoundpoorercontrolassociatedshorterinitiatedcurativesuspendedparticularlyinstitutionalcontextreferralsteamessentialrelievesymptom-relateddistressimproveoutcomespeopleIntensitySymptomsPerceptionQualityLifeAdmissionCare:RealityPortugueseTeamoutcome

Similar Articles

Cited By

No available data.